Consensus Sanofi Mexican S.E.

Equities

SAN1 N

FR0000120578

End-of-day quote Mexican S.E. Other stock markets 23:00:00 30/10/2023 GMT			5-day change	1st Jan Change
1,629 ^MXN	+1.22%		-.--%	-.--%

07-03	Bain, Cinven Said to Weigh Joint Bid for Sanofi's Consumer Health Division	MT
07-03	Bain, Cinven Said to Weigh Joint Bid for Sanofi's Consumer Health Division	MT

Evolution of the average Target Price on Sanofi

Price target over the last 5 years

History of analyst recommendation changes

47e5c9ccddd6f001d24f2f.lT5_ZKC6CiXZkqShr4ueYI1vzzMgD0WN11ITtc2gCHQ.zVZKJtjsOGzro-jm__HMWdkLpnR0Yhb85BVd7YfaYBX6UxEN6dVhYpfDlA~0081ec28cbbf17d7389542a539ffa737

Analyst Recommendations on Sanofi

SANOFI : Berenberg reiterates its Buy rating	07-03	ZD
SANOFI : JP Morgan remains Neutral	07-03	ZD
SANOFI : Jefferies reaffirms its Buy rating	07-02	ZD
SANOFI : Receives a Buy rating from Berenberg	07-02	ZD
SANOFI : UBS remains its Buy rating	06-25	ZD
SANOFI : JP Morgan sticks Neutral	06-24	ZD
SANOFI : UBS reiterates its Buy rating	06-04	ZD
SANOFI : Gets a Neutral rating from JP Morgan	06-03	ZD
SANOFI : Sell rating from Deutsche Bank	05-13	ZD
SANOFI : Berenberg maintains a Buy rating	05-13	ZD
Novavax Stock Price More Than Doubles After COVID-19 Vaccine Licensing Deal With Sanofi	05-10	MT
SANOFI : UBS gives a Buy rating	05-10	ZD
HEDGE FUND SHAH CAPITAL SAYS NOVAVAX-SANOFI DEAL IS "A STEP IN T…	05-10	RE
HEDGE FUND SHAH CAPITAL - NOVAVAX-SANOFI DEAL CONCURS WITH SHAH…	05-10	RE
SANOFI : JP Morgan reaffirms its Neutral rating	05-10	ZD
Bank of America, BNP Set to Win Lead Roles on Sanofi's Consumer-Healthcare Spin Off	05-06	MT
SANOFI : Buy rating from UBS	05-06	ZD
SANOFI : Jefferies reiterates its recommendation on the stock	04-29	CF
SANOFI : Deutsche Bank gives a Sell rating	04-29	ZD
SANOFI : JP Morgan remains Neutral	04-29	ZD
SANOFI : DZ Bank reaffirms its Neutral rating	04-25	ZD
SANOFI : Jefferies reiterates its Buy rating	04-25	ZD
SANOFI : Sanofi’s healthy Q1 performance hailed by markets	04-25
SANOFI : Bernstein remains its Buy rating	04-24	ZD
SANOFI : Gets a Buy rating from UBS	04-22	ZD

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

90.23 EUR

Average target price

108.1 EUR

Spread / Average Target

+19.79%

High Price Target

125 EUR

Spread / Highest target

+38.53%

Low Price Target

80 EUR

Spread / Lowest Target

-11.34%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Sanofi

JEFFERIES	Peter Welford
BERENBERG	Luisa Hector
UBS	Jo Walton
JPMORGAN	Richard Vosser
DEUTSCHE BANK RESEARCH	Emmanuel Papadakis
alphavalue	Abhishek Raval
DZ BANK	Elmar Kraus
BERNSTEIN RESEARCH	Florent Cespedes
BARCLAYS	Emily Field
Berenberg Bank
CREDIT SUISSE	Dominic Lunn
Argus
GOLDMAN SACHS	Keyur Parekh
MORGAN STANLEY	Mark Purcell
Kepler Cheuvreux
DEUTSCHE BANK	Emmanuel Papadakis
Stifel Nicolaus
Liberum Capital
SVB Leerink
BAADER BANK
Deutsche Bank Securities
ODDO BHF
HSBC	Julie Mead
BANK OF AMERICA (BOFA)	Sachin Jain

Ratings for Sanofi

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar